Reuters
2022.08.03 08:24

Sumitomo Pharma Co Ltd: Notice Of Conclusion Of Sales Collaboration For Glp-1 Receptor Agonist "Trulicity Subcutaneous Injection 0.75 Mg Ateos"

Aug 3 (Reuters) - Sumitomo Pharma Co Ltd (4506.T) : * NOTICE OF CONCLUSION OF SALES COLLABORATION FOR GLP-1 RECEPTOR AGONIST "TRULICITY SUBCUTANEOUS INJECTION 0.75 MG ATEOS"
The copyright of this article belongs to the original author/organization.
The current content only represents the author’s point of view, and has nothing to do with the position of Longbridge. The content is for investment reference only and does not constitute any investment advice. If you have any questions or suggestions about the content services provided by Longbridge, please contact: editorial@longbridge.global

Like